View in EDS

Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary.

Saved in:
Bibliographic Details
Title: Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary.
Authors: Moore, Kathleen N.1 (AUTHOR) kathleen-moore@ouhsc.edu, Lorusso, Domenica2 (AUTHOR), Oaknin, Ana3 (AUTHOR), Oza, Amit4 (AUTHOR), Colombo, Nicoletta5,6 (AUTHOR), Van Gorp, Toon7 (AUTHOR), O'Malley, David M.8 (AUTHOR), Banerjee, Susana9 (AUTHOR), Murphy, Conleth G.10 (AUTHOR), Harter, Philipp11 (AUTHOR), Konecny, Gottfried E.12 (AUTHOR), Pautier, Patricia13 (AUTHOR), Method, Michael14 (AUTHOR), Wang, Yuemei14 (AUTHOR), Coleman, Robert L.15 (AUTHOR), Birrer, Michael16 (AUTHOR), Matulonis, Ursula A.17 (AUTHOR)
Source: Gynecologic Oncology. Dec2024, Vol. 191, p249-258. 10p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2024.10.013